A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
Clinical trial NCT00721669 · COMPLETED
Trial details
- NCT number
- NCT00721669
- Sponsor
- ImmunoGen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2012-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.